The following tables are from Resource (1) [For details on anything in the tables, please see Resource (2)]:
G.R. Dohle (Chair), S. Arver, C. Bettocchi, T.H. Jones, S. Kliesch, M. Punab
Male hypogonadism is a clinical syndrome caused by androgen deficiency which may adversely affect multiple organ functions and quality of life. Androgen deficiency increases slightly with age. In middle-aged men the incidence is 6%. Hypogonadism is more prevalent in older men, in men with obesity, those with co-morbidities, and in men with a poor health status.
Aetiology and classification
- Male hypogonadism can be classified in accordance with disturbances at the level of:
- the testes (primary hypogonadism);
- the hypothalamus and pituitary (secondary hypogonadism);
- the hypothalamus/pituitary and gonads (hypogonadism in adult men);
- androgen target organs (androgen insensitivity/resistance).
Pocket Guidelines: EAU GUIDELINES ON MALE HYPOGONADISM [Full Text HTML]
(Text update March 2015)
Guidelines on Male Hypogonadism [Full Text HTML – This link is not fully functional] [Full Text PDF] 2015 European Association of Urology.
European Association of Urology Links to All Non-oncology Guidelines